Skip navigation
  • Sciety Labs đź§Ş (Experimental)
  • Search
Sciety application utilities

Immunology

  • Subscribe to feed (RSS)

Showing page 115 of 175 pages of list content

  • Single-dose AAV-based vaccine induces a high level of neutralizing antibodies against SARS-CoV-2 in rhesus macaques

    This article's authors
    1. Dali Tong
    2. Mei Zhang
    3. Yunru Yang
    4. Han Xia
    5. Haiyang Tong
    6. Huajun Zhang
    7. Weihong Zeng
    8. Muziying Liu
    9. Yan Wu
    10. Huan Ma
    11. Xue Hu
    12. Weiyong Liu
    13. Yuan Cai
    14. Yanfeng Yao
    15. Yichuan Yao
    16. Kunpeng Liu
    17. Shifang Shan
    18. Yajuan Li
    19. Ge Gao
    20. Weiwei Guo
    21. Yun Peng
    22. Shaohong Chen
    23. Juhong Rao
    24. Jiaxuan Zhao
    25. Juan Min
    26. Qingjun Zhu
    27. Yanmin Zheng
    28. Lianxin Liu
    29. Chao Shan
    30. Kai Zhong
    31. Zilong Qiu
    32. Tengchuan Jin
    33. Sandra Chiu
    34. Zhiming Yuan
    35. Tian Xue
    This article has 1 evaluations Latest evaluation on May 23, 2021 Published on May 9, 2022
  • Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition

    This article's authors
    1. Kevin J. Kramer
    2. Nicole V. Johnson
    3. Andrea R. Shiakolas
    4. Naveenchandra Suryadevara
    5. Sivakumar Periasamy
    6. Nagarajan Raju
    7. Jazmean K. Williams
    8. Daniel Wrapp
    9. Seth J. Zost
    10. Clinton M. Holt
    11. Ching-Lin Hsieh
    12. Rachel E. Sutton
    13. Ariana Paulo
    14. Edgar Davidson
    15. Benjamin J. Doranz
    16. James E. Crowe
    17. Alexander Bukreyev
    18. Robert H. Carnahan
    19. Jason S. McLellan
    20. Ivelin S. Georgiev
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 16, 2021
  • Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice

    This article's authors
    1. Ralf Salzer
    2. Jordan J. Clark
    3. Marina Vaysburd
    4. Veronica T. Chang
    5. Anna Albecka
    6. Leo Kiss
    7. Parul Sharma
    8. Andres Gonzalez Llamazares
    9. Anja Kipar
    10. Julian A. Hiscox
    11. Andrew Owen
    12. A. Radu Aricescu
    13. James P. Stewart
    14. Leo C. James
    15. Jan Löwe
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 24, 2021
  • The Spike Proteins of SARS-CoV-2 B.1.617 and B.1.618 Variants Identified in India Provide Partial Resistance to Vaccine-elicited and Therapeutic Monoclonal Antibodies

    This article's authors
    1. Takuya Tada
    2. Hao Zhou
    3. Belinda M. Dcosta
    4. Marie I. Samanovic
    5. Mark J. Mulligan
    6. Nathaniel R. Landau
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 16, 2021
  • Broad neutralization against SARS-CoV-2 variants induced by a modified B.1.351 protein-based COVID-19 vaccine candidate

    This article's authors
    1. Danmei Su
    2. Xinglin Li
    3. Cui He
    4. Xueqing Huang
    5. Meilin Chen
    6. Qiang Wang
    7. Wenchang Qin
    8. Ying Liang
    9. Rong Xu
    10. Jinhua Wu
    11. Peiwen Luo
    12. Xiaofang Yang
    13. Yilan Zeng
    14. Mei Luo
    15. Dongxia Luo
    16. David M Salisbury
    17. Donna Ambrosino
    18. George Siber
    19. Ralf Clemens
    20. Peng Liang
    21. Joshua G. Liang
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 17, 2021
  • CD147 antibody specifically and effectively inhibits infection and cytokine storm of SARS-CoV-2 variants

    This article's authors
    1. Jiejie Geng
    2. Liang Chen
    3. Yufeng Yuan
    4. Ruo Chen
    5. Ke Wang
    6. Yongqiang Deng
    7. Peng Du
    8. Jiangning Liu
    9. Guizhen Wu
    10. Youchun Wang
    11. Ke Xu
    12. Xiuxuan Sun
    13. Ting Guo
    14. Xu Yang
    15. Jiao Wu
    16. Jianli Jiang
    17. Ling Li
    18. Jun Zhang
    19. Kui Zhang
    20. Hua Zhu
    21. Zhaohui Zheng
    22. Xianghui Fu
    23. Fengfan Yang
    24. Xiaochun Chen
    25. Hao Tang
    26. Zheng Zhang
    27. Ding Wei
    28. Yang Zhang
    29. Ying Shi
    30. Yumeng Zhu
    31. Zhuo Pei
    32. Fei Huo
    33. Shirui Chen
    34. Qingyi Wang
    35. Wen Xie
    36. Yirong Li
    37. Mingyan Shi
    38. Huijie Bian
    39. Ping Zhu
    40. Zhi-Nan Chen
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 15, 2021
  • Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants

    This article's authors
    1. Amarendra Pegu
    2. Sarah O’Connell
    3. Stephen D Schmidt
    4. Sijy O’Dell
    5. Chloe A. Talana
    6. Lilin Lai
    7. Jim Albert
    8. Evan Anderson
    9. Hamilton Bennett
    10. Kizzmekia S. Corbett
    11. Britta Flach
    12. Lisa Jackson
    13. Brett Leav
    14. Julie E. Ledgerwood
    15. Catherine J. Luke
    16. Mat Makowski
    17. Paul C. Roberts
    18. Mario Roederer
    19. Paulina A. Rebolledo
    20. Christina A. Rostad
    21. Nadine G. Rouphael
    22. Wei Shi
    23. Lingshu Wang
    24. Alicia T. Widge
    25. Eun Sung Yang
    26. the mRNA-1273 Study Group
    27. John H. Beigel
    28. Barney S. Graham
    29. John R Mascola
    30. Mehul S. Suthar
    31. Adrian McDermott
    32. Nicole A. Doria-Rose
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 16, 2021
  • Fc-independent neutralization of SARS-CoV-2 by recombinant human monoclonal antibodies

    This article's authors
    1. Tal Noy-Porat
    2. Avishay Edri
    3. Ron Alcalay
    4. Efi Makdasi
    5. David Gur
    6. Moshe Aftalion
    7. Yentl Evgy
    8. Adi Beth-Din
    9. Yinon Levy
    10. Eyal Epstein
    11. Olga Radinsky
    12. Ayelet Zauberman
    13. Shirley Lazar
    14. Shmuel Yitzhaki
    15. Hadar Marcus
    16. Angel Porgador
    17. Ronit Rosenfeld
    18. Ohad Mazor
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 15, 2021
  • Safety, immunogenicity and protection provided by unadjuvanted and adjuvanted formulations of recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in non-human primates

    This article's authors
    1. Stéphane Pillet
    2. Prabhu S. Arunachalam
    3. Guadalupe Andreani
    4. Nadia Golden
    5. Jane Fontenot
    6. Pyone Aye
    7. Katharina Röltgen
    8. Gabrielle Lehmick
    9. Charlotte Dubé
    10. Philipe Gobeil
    11. Sonia Trépanier
    12. Nathalie Charland
    13. Marc-André D’Aoust
    14. Kasi Russell-Lodrigue
    15. Robert V. Blair
    16. Scott Boyd
    17. Rudolph B. Bohm
    18. Jay Rappaport
    19. François Villinger
    20. Brian J. Ward
    21. Bali Pulendran
    22. Nathalie Landry
    This article has 1 evaluations Latest evaluation on May 21, 2021 Published on May 15, 2021
  • Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection

    This article's authors
    1. Luisa Cervantes-Barragan
    2. Abigail Vanderheiden
    3. Charlotte J. Royer
    4. Meredith E. Davis-Gardner
    5. Philipp Ralfs
    6. Tatiana Chirkova
    7. Larry J. Anderson
    8. Arash Grakoui
    9. Mehul S. Suthar
    This article has 1 evaluations Latest evaluation on May 16, 2021 Published on May 13, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information